Published on

Infectious Disease and Microbiology – Tetanus

Tetanus is a toxin-mediated neurologic disease caused by Clostridium tetani and is characterized by persistent muscle rigidity and painful tonic spasms. Four major clinical forms are recognized: generalized, localized, cephalic, and neonatal tetanus.


Epidemiology

Tetanus is now uncommon in countries with effective vaccination programs, but it remains an important cause of morbidity and mortality in regions where immunization coverage is incomplete.


The disease can occur even in previously vaccinated individuals, although this is exceedingly rare when adequate protective immunity is present.


In developed countries, older adults are particularly vulnerable because protective antitoxin levels decline with age, especially when booster vaccination has not been maintained.


Risk factors

Most cases of non-neonatal tetanus occur after a soft-tissue injury, particularly puncture wounds or wounds contaminated with soil, foreign material, or devitalized tissue.


Other important risk factors include incomplete vaccination, advanced age, injection-drug use, burns, avulsion injuries, animal bites, and wounds containing necrotic tissue.


Neonatal tetanus primarily occurs when infants are born to inadequately immunized mothers and the umbilical stump becomes contaminated.


Prevention

Tetanus prevention depends primarily on routine vaccination with tetanus toxoid-containing vaccines and appropriate wound management.


Children receive a primary vaccination series containing diphtheria, tetanus, and pertussis antigens, followed by booster doses later in life.


Adults require periodic booster vaccination to maintain protection.


For contaminated or major wounds, patients with an incomplete or uncertain primary vaccination history may require both tetanus toxoid-containing vaccine and tetanus immune globulin (TIG).


Patients who have completed the primary vaccine series may require a booster according to the type of wound and the interval since their last tetanus-containing vaccine.


Thorough wound cleaning, removal of foreign material, and debridement of devitalized tissue further reduce the risk of disease.


Pathophysiology

Clostridium tetani is an anaerobic, spore-forming bacterium widely distributed in soil and the environment.


The organism usually germinates in devitalized or poorly oxygenated tissue, where it produces the potent neurotoxin tetanospasmin.


Tetanospasmin travels along peripheral nerves toward the central nervous system and interferes with the release of inhibitory neurotransmitters.


Loss of inhibitory control over motor neurons produces persistent muscle contraction, rigidity, and painful reflex spasms.


The toxin may also disrupt autonomic nervous system regulation, resulting in severe fluctuations in blood pressure and heart rate.


Generalized tetanus

Generalized tetanus is the most common and clinically recognizable form.


The onset is often gradual over several days and commonly begins with trismus, or lockjaw.


Facial muscle contraction may produce the characteristic grimacing expression known as risus sardonicus.


Patients frequently develop neck stiffness, difficulty swallowing, abdominal rigidity, and generalized painful muscle spasms.


Consciousness usually remains intact, making the spasms especially distressing and painful.


Spasms may be triggered by touch, noise, light, or other minor stimuli.


Severe contractions can compromise the upper airway or involve the diaphragm and intercostal muscles, producing apnea and respiratory failure.


Localized tetanus

Localized tetanus produces persistent muscle rigidity near the site of inoculation.


It may remain limited to one region, but in some patients it represents an early stage that later progresses to generalized tetanus.


Cephalic tetanus

Cephalic tetanus is an uncommon form associated with head or neck wounds.


It affects cranial motor nerves and may initially present with trismus, dysphagia, facial weakness, or other cranial nerve abnormalities.


Neonatal tetanus

Neonatal tetanus usually develops during the first two weeks of life in infants born to mothers without adequate tetanus immunity.


An early sign is difficulty or inability to suckle normally, followed by generalized rigidity and painful spasms.


The disease carries a particularly high mortality when intensive supportive treatment is unavailable.


Physical examination

The original wound may be very small, apparently healed, or difficult to identify by the time neurologic manifestations appear.


Early symptoms can include jaw stiffness, sore throat, difficulty swallowing, and muscle tightness.


Severe generalized tetanus may produce opisthotonos, in which intense contraction of the back muscles causes marked arching of the body.


The arms may become flexed while the legs remain extended and rigid.


Spasms of the respiratory muscles can produce recurrent episodes of apnea and hypoxemia.


As the disease progresses, autonomic dysfunction may cause alternating episodes of hypertension and hypotension, tachycardia and bradycardia, sweating, and cardiac instability.


Diagnosis

Tetanus is primarily a clinical diagnosis.


There is no laboratory test capable of reliably confirming or excluding the disease.


A history of a recent wound, especially one contaminated by soil, foreign material, or devitalized tissue, should be actively sought.


Routine blood counts and chemistry studies are often nonspecific or normal.


Imaging of the brain and spine is generally normal and is primarily used to exclude alternative neurologic disorders.


Differential diagnosis

Strychnine poisoning is one of the closest clinical mimics because it also causes severe stimulus-induced muscle spasms.


Other conditions that may resemble aspects of tetanus include drug-induced dystonic reactions, dental or pharyngeal infections causing trismus, encephalitis, seizures, hypocalcemic tetany, and other neurologic disorders.


Unlike many of these conditions, tetanus typically combines preserved consciousness, sustained rigidity, painful reflex spasms, and a compatible wound history.


Treatment

Treatment is directed toward neutralizing unbound toxin, eliminating the source of toxin production, controlling spasms, maintaining ventilation, and managing autonomic instability.


Once tetanospasmin has bound to neural tissue, its effect cannot be rapidly reversed. Recovery therefore depends on the formation of new functional nerve terminals over time.


Tetanus immune globulin

Human tetanus immune globulin (TIG) should be administered as soon as possible to neutralize circulating toxin that has not yet bound to nerve tissue.


TIG does not reverse toxin already attached to neurons but can limit further progression.


Antimicrobial therapy

Antibiotics are used to eliminate C. tetani from the wound and stop further toxin production.


Metronidazole is commonly preferred and is usually given for approximately 7–10 days.


Penicillin has historically been used but is generally considered an alternative.


Control of muscle spasms

Benzodiazepines, particularly diazepam or similar agents, are major components of symptomatic treatment because they reduce muscle spasms and provide sedation.


Severe spasms may require very large doses under intensive monitoring.


When sedation alone is insufficient, neuromuscular blocking agents such as vecuronium may be required, with simultaneous mechanical ventilation.


Other agents, including baclofen, opioids, or additional sedatives, may be considered in selected severe cases.


Autonomic instability

Severe tetanus can produce profound autonomic dysfunction with rapidly fluctuating cardiovascular parameters.


Magnesium sulfate may help reduce autonomic instability and muscle activity.


Additional medications may be required to control severe hypertension, tachycardia, or other cardiovascular abnormalities.


Wound management

All suspected tetanus wounds require careful exploration, cleaning, and surgical debridement when appropriate.


Removal of necrotic tissue, foreign bodies, and areas of poor oxygenation decreases the number of toxin-producing organisms.


Vaccination after tetanus

Clinical tetanus does not reliably produce protective immunity, so patients must still receive active tetanus vaccination after stabilization.


A tetanus-containing vaccine should therefore be administered as part of the recovery plan, with completion of the appropriate vaccine series afterward.


In-patient management

Generalized tetanus usually requires management in an intensive care unit.


Patients should ideally be treated in a quiet environment because external stimuli can provoke severe spasms.


Airway protection and mechanical ventilation may be necessary for prolonged periods.


Close cardiovascular monitoring is essential because autonomic instability can be life-threatening.


Nutritional support

Severe tetanus produces markedly increased metabolic demands because of repeated muscle contractions and prolonged critical illness.


Patients often require high-calorie enteral nutritional support.


Long-term enteral feeding through a feeding tube or gastrostomy may be necessary in patients with prolonged dysphagia or mechanical ventilation.


Follow-up and recovery

Recovery from generalized tetanus is slow and commonly takes several weeks or longer.


Neuromuscular function improves gradually as new nerve terminals form and inhibitory neurotransmission returns.


Patients may require prolonged physical rehabilitation, nutritional support, respiratory care, and psychological support after survival from severe disease.


Prognosis

Mild and moderate tetanus have substantially better outcomes than severe generalized or neonatal disease.


Mortality increases with rapid onset of symptoms, short incubation period, severe autonomic dysfunction, respiratory failure, advanced age, and limited access to intensive care.


Neonatal and severe generalized tetanus carry the greatest risk of death.


Complications

The most serious complications include airway obstruction, respiratory failure, aspiration pneumonia, prolonged mechanical ventilation, severe autonomic instability, cardiac arrhythmias, and cardiovascular collapse.


Forceful spasms can also cause fractures, muscle injury, rhabdomyolysis, and vertebral compression injuries.


Prolonged immobility may result in deep-vein thrombosis, pressure injuries, nosocomial infections, and profound deconditioning.


High-Yield Pattern

Contaminated wound + trismus + painful muscle spasms → strongly consider tetanus


Risus sardonicus + abdominal rigidity + stimulus-induced spasms → generalized tetanus


Opisthotonos + preserved consciousness → classic severe tetanus


Newborn unable to suck followed by rigidity and spasms → neonatal tetanus


Diagnosis → clinical; there is no reliable confirmatory laboratory test


Treatment → TIG + wound debridement + metronidazole + aggressive spasm and airway control


Having tetanus does not produce dependable immunity → vaccination is still required



0 Comments